v3.26.1
Investment in equity investees (Details 6)
¥ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2025
CNY (¥)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
CNY (¥)
Dec. 31, 2023
CNY (¥)
Dec. 31, 2025
USD ($)
Operating data:          
Net (loss)/income ¥ 23,142 $ 3,309 ¥ 44,660 ¥ 23,257  
Balance sheet data:          
Current assets 374,421   386,698   $ 53,541
Non-current assets 320,780   311,536   45,871
Current liabilities 306,072   299,521   43,768
Non-current liabilities 95,346   85,416   13,634
Non-controlling interests 68,743   73,466   $ 9,830
Share of results of equity investees          
Equity method investments          
Impairment charges in connection with the equity method 88   699 266  
Equity Method Investments          
Operating data:          
Revenues 104,075   146,583 149,237  
Gross profit 56,510   70,000 48,134  
(Loss)/income from operations 20,597   8,334 (274)  
Net (loss)/income 17,846   4,380 (1,733)  
Net (loss)/income attributable to the investees' ordinary shareholders 17,990   4,641 ¥ (1,506)  
Balance sheet data:          
Current assets 154,476   161,218    
Non-current assets 145,184   146,848    
Current liabilities 122,333   124,013    
Non-current liabilities 48,705   44,090    
Redeemable stock 0   28,167    
Non-controlling interests ¥ 4,534   ¥ 4,429